MAZE · Maze Therapeutics, Inc.
$29.58
-0.84 (-2.76%)
At close · Aug 26
Market Cap
$1.65B
Shares
55.55M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-17 | 2026-08-13 | |
| 8-K | 2026-08-11 | — | |
| 10-Q | 2026-08-11 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-10 | 2026-06-08 | |
| Investor Event Transcript | 2026-06-10 | 2026-06-30 | |
| 8-K | 2026-05-22 | 2026-05-18 | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-12 | — | |
| DEF 14A | 2026-04-28 | 2026-06-08 | |
| 8-K | 2026-04-22 | 2026-04-21 | |
| 10-K | 2026-03-25 | 2025-12-31 | |
| 8-K | 2026-03-25 | 2026-03-24 | |
| 8-K | 2026-02-04 | 2026-02-02 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-10-06 | — | |
| 8-K | 2025-09-11 | 2025-09-10 | |
| 8-K | 2025-09-02 | — | |
| 8-K | 2025-08-12 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-05-14 | — | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 8-K | 2025-03-31 | — |
Showing 1–25 of 25 filings
Key facts
CIK
1842295
CUSIP
578784100
13F (30d)
151 filings
150 filers
Visit website
Investor relations